204 related articles for article (PubMed ID: 6099816)
1. Glucose-induced GIP levels in patients with insulinoma.
Tamburrano G; Lala A; Mauceri M; Leonetti F; Andreani D
Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
[TBL] [Abstract][Full Text] [Related]
2. Interrelationships among insulin, glucagon, and gastric inhibitory polypeptide in insulinoma.
Nelson RL; Service FJ; Go VL
Mayo Clin Proc; 1980 Mar; 55(3):138-45. PubMed ID: 6243728
[TBL] [Abstract][Full Text] [Related]
3. Insulin modulates glucose-dependent insulinotropic polypeptide (GIP) secretion from enteroendocrine K cells in rats.
Irwin N; Francis JM; Flatt PR
Biol Chem; 2011 Oct; 392(10):909-18. PubMed ID: 21851286
[TBL] [Abstract][Full Text] [Related]
4. Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum.
Schattenmann G; Ebert R; Siewert R; Creutzfeldt W
Scand J Gastroenterol; 1984 Mar; 19(2):260-6. PubMed ID: 6372074
[TBL] [Abstract][Full Text] [Related]
5. [Insulin assay in insulinoma].
Zeng XJ
Zhonghua Wai Ke Za Zhi; 1984 Jan; 22(1):13-8, 62. PubMed ID: 6097422
[No Abstract] [Full Text] [Related]
6. Lack of diabetogenic action of calcitonin in subjects affected by insulinoma.
Passariello N; Paolisso G; Iannuzzi F; Pizza G; Marrazzo G; Sgambato S; D'Onofrio F
Diabete Metab; 1989; 15(2):88-92. PubMed ID: 2544469
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactive insulin assay in insulinoma.
Zeng XJ; Yao CZ; Zhong SX; Zhang JX; Zhu Y; Wu CY
Chin Med J (Engl); 1983 Aug; 96(8):575-82. PubMed ID: 6315315
[No Abstract] [Full Text] [Related]
8. The correlation between gastric emptying time and the response of GIP and enteroglucagon to oral glucose in duodenal ulcer patients.
Lauritsen KB; Frederiksen HJ; Uhrenholdt A; Holst JJ
Scand J Gastroenterol; 1982 Jun; 17(4):513-6. PubMed ID: 6753108
[TBL] [Abstract][Full Text] [Related]
9. Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms.
Renard E; Parer-Richard C; Richard JL; Jureidini S; Orsetti A; Mirouze J
Diabete Metab; 1991; 17(3):355-62. PubMed ID: 1884880
[TBL] [Abstract][Full Text] [Related]
10. Rapid assay of insulin in portosplenic blood for insulinoma.
Yao CZ; Zeng XJ; Niu ZP
Chin Med J (Engl); 1984 Jan; 97(1):57-60. PubMed ID: 6329612
[No Abstract] [Full Text] [Related]
11. Hyperinsulinism, glucose-dependent insulinotropic polypeptide, and the enteroinsular axis in morbidly obese patients before and after gastric bypass.
Sirinek KR; O'Dorisio TM; Hill D; McFee AS
Surgery; 1986 Oct; 100(4):781-7. PubMed ID: 3532392
[TBL] [Abstract][Full Text] [Related]
12. The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.
Lauritsen KB; Moody AJ
Diabetologia; 1978 Mar; 14(3):149-53. PubMed ID: 658630
[TBL] [Abstract][Full Text] [Related]
13. The association between plasma GIP and insulin after oral glucose.
Lauritsen KB; Moody AJ
Scand J Gastroenterol; 1980; 15(8):953-7. PubMed ID: 7015475
[TBL] [Abstract][Full Text] [Related]
14. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.
Lauritzen JB; Lauritsen KB; Olsen ME; Timmerman I
Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641
[TBL] [Abstract][Full Text] [Related]
15. Absence of effect of calcium perfusion on blood sugar and plasma insulin in a patient with a benign insulinoma.
Pointel JP; Villaume C; Gay G; Drouin P; Debry G
Horm Metab Res; 1978 Nov; 10(6):572-3. PubMed ID: 217813
[No Abstract] [Full Text] [Related]
16. Discrepant performance on oral and intravenous glucose tolerance tests: the role of gastric inhibitory polypeptide.
Elahi D; Andersen DK; Tobin JD; Andres R
J Clin Endocrinol Metab; 1981 Jun; 52(6):1199-203. PubMed ID: 7014599
[TBL] [Abstract][Full Text] [Related]
17. Gastric inhibitory polypeptide and insulin: response to intraduodenal and intravenous glucose infusions in fetal and neonatal pigs.
Kühl C; Hornnes PJ; Jensen SL; Lauritsen KB
Endocrinology; 1980 Nov; 107(5):1446-50. PubMed ID: 7000494
[TBL] [Abstract][Full Text] [Related]
18. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
Nakanome C; Akai H; Umezu M; Toyota T; Goto Y
Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
[TBL] [Abstract][Full Text] [Related]
19. Gastric inhibitory polypeptide response to hyper- and hypoglycemia in insulin-dependent diabetics.
Reynolds C; Tronsgard N; Gibbons E; Blix PM; Rubenstein AH
J Clin Endocrinol Metab; 1979 Aug; 49(2):255-61. PubMed ID: 457845
[TBL] [Abstract][Full Text] [Related]
20. Effects of physical training on insulin, connecting peptide (C-peptide), gastric inhibitory polypeptide (GIP) and pancreatic polypeptide (PP) levels in obese subjects.
Krotkiewski M; Björntorp P; Holm G; Marks V; Morgan L; Smith U; Feurle GE
Int J Obes; 1984; 8(3):193-9. PubMed ID: 6378815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]